Skip to main content
Log in

A new method for assaying antimicrobials in the prostate

Neue Methode zur Bestimmung antimikrobieller Substanzen in der Prostata

  • Therapy
  • Published:
Infection Aims and scope Submit manuscript

Summary

In this study we collected prostatectomy specimens from 20 men receiving selected preoperative antimicrobials: oral carbenicillin, norfloxacin, or ciprofloxacin. The prostatectomy specimens were then individually separated into stroma and epithelium. The intraprostatic differential concentrations were determined using High Performance Liquid Chromatography. The ratio of stromal to epithelial concentrations of the antimicrobials were calculated for carbenicillin (0.95), norfloxacin (1.28), and ciprofloxacin (1.1). The quinolones tended to have higher stromal concentrations (although this was not statistically significant). Carbenicillin was found in levels three times its MIC90 forEscherichia coli while the quinolones were detected in concentrations which greatly exceeded theirE. coli MIC90s.

Zusammenfassung

Von 20 Patienten, die präoperativ Carbenicillin, Norfloxacin oder Ciprofloxacin oral verabreicht bekommen hatten, wurden bei der Prostatektomie Gewebeproben gewonnen. In jedem Fall wurden die Proben nach Stroma und Epithel getrennt. Die Konzentrationen im jeweiligen Gewebeanteil wurden mittels Hochdruckflüssigkeitschromatographie gemessen. Der Quotient aus Konzentration in Stroma und Epithel war bei Carbenicillin 0,95, bei Norfloxacin 1,28 und bei Ciprofloxacin 1,1, das heißt die Chinolone zeigten eine Tendenz zu höheren Konzentrationen im Stroma als im Epithel (dieser Unterschied war jedoch nicht statistisch signifikant). Nach oraler Gabe hatte Carbenicillin in der Prostata die dreifachen Konzentrationen der MHK90-Werte fürEscherichia coli erreicht, die Konzentrationen der Chinolone lagen weit über den MHK90-Werten fürEscherichia coli.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Stamey, T. A., Mears, E. M., Winningham, D. G. Chronic bacterial prostatitis and the diffusion of drugs into prostatic fluid. J. Urol. 103 (1970) 187–194.

    Google Scholar 

  2. Mears, E. M. Prostatitis syndromes: new perspectives about old woes. J. Urol. 123 (1980) 141–147.

    Google Scholar 

  3. Twomey, P. A. High performance liquid chromatography analysis of carbenicillin and its degradation products. J. Pharm. Sci. 70 (7) (1981) 824–826.

    Google Scholar 

  4. Boppana, V. K., Swanson, B. N. Determination of norfloxacin, a new nalidixic acid analog, in human serum and urine by high performance liquid chromatography. Antimicrob. Agents Chemother. 21 (5) (1982) 808–810.

    Google Scholar 

  5. Anderson, R. U., Fair, W. R. Physical and chemical determinations of prostatic secretions, in benign hyperplasia, prostatitis, and adenocarcioma. Invest. Urol. 14 (1976) 137.

    Google Scholar 

  6. Pfau, A., Perlberg, S., Shapira, A. The pH of the prostatic fluid in health and disease: implications of the treatment in chronic bacterial prostatitis. J. Urol. 119 (1978) 354.

    Google Scholar 

  7. Dalhoff, W., Weidner, W. Diffusion of ciprofloxacin into the prostatic fluid. Eur. J. Clin. Microbiol. 3 (4) (1984) 360–362.

    Google Scholar 

  8. Boerema, J. B. J., Debruyne, F. M. J., Dalhoff, A. Intraprostatic concentrations of ciprofloxacin after intravenous administration. Letter. Lancet ii (1984) 695–696.

    Google Scholar 

  9. Naber, K. G. Use of quinolones in urinary tract infections and prostatitis. Rev. Infect. Dis. 11 (Suppl. 5) (1989) S1321-S1337.

    Google Scholar 

  10. Bergeron, M. G., Thabet, M., Ror, R., Lessard, C., Foucault, P. Norfloxacin into human renal and prostatic tissues. Antimicrob. Agents Chemother. 28 (2) (1986) 349–350.

    Google Scholar 

  11. Bologna, M., Vaggi, L., Fouchetti, C. M., Martini, E. Bactericidal intraprostatic concentrations of norfloxacin. Lancet ii (1983) 280.

    Google Scholar 

  12. Gombert, M. E., duBouchat, L., Aulicino, T. M., Berkowitz, L. B., Macchin, R. J. Brief report: prostatic tissue concentrations of ciprofloxacin after oral administration. Am. J. Med. 82 (Suppl. 4a) (1987) 130–132.

    Google Scholar 

  13. Bologna, M., Vaggi, L., Flammini, D., Carlucci, G., Forchette, C. M. Norfloxacin in prostatitis: correlation between HPLC tissue concentrations and clinical results. Drugs Exp. Clin. Res. XI (2) (1985) 95–100.

    Google Scholar 

  14. Grabe, M., Forsgren, A., Bjork, T. Concentrations of ciprofloxacin in serum and prostatic tissue in patients undergoing transurethral resection. Eur. J. Clin. Microbiol. 5 (2) (1986) 211–212.

    Google Scholar 

  15. Dan, M., Golomb, J., Gorea, A., Braf, Z., Berger, S. A. Concentration of ciprofloxacin in human prostatic tissue after oral administration. Antimicrob. Agents Chemother. 30 (1986) 88–89.

    Google Scholar 

  16. Wallace, J. F., Atlas, E., Bear, D. M., Brown, N. K., Clark, H., Turck, M. Evaluation of an indanyl ester of carbenicillin. Antimicrob. Agents Chemother. 10 (1970) 223–226.

    Google Scholar 

  17. Sanders, C. C., Sanders, W. E., Goerig, R. V. Overview of preclinical studies with ciprofloxacin. Am. J. Med. 82 (Suppl. 4a) (1987) 2–11.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Philpott, A.C., Crawford, E.D. & Miller, G.J. A new method for assaying antimicrobials in the prostate. Infection 19 (Suppl 3), S150–S153 (1991). https://doi.org/10.1007/BF01643686

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01643686

Keywords

Navigation